Intermittent ST depression and mortality after myocardial infarction

Area of Science:

• Cardiology
• Clinical Research
• Morbidity and Mortality Studies

Background:

• Assessing the impact of intermittent ST depression (STD) on mortality in post-myocardial infarction (MI) patients.
• Utilizing data from the Beta Blocker Heart Attack Trial for a case-control analysis.

Purpose of the Study:

• To determine the contribution of intermittent ST depression to mortality.
• To investigate the potential protective effect of propranolol against STD-associated mortality.

Main Methods:

• Computer analysis of 24-hour ECG tapes to detect ST depression (>= 0.1 mV for >= 1 minute).
• Verification of computer-detected ST events by trained readers.
• Case-control analysis comparing 261 deaths with matched controls, adjusting for covariates.

Main Results:

• Intermittent ST depression (STD) was associated with a relative risk (RR) of 1.73 for mortality.
• In untreated patients, STD showed a higher RR of 2.56, while in propranolol-treated patients, the RR was 0.98.
• A dose-dependent relationship was observed in the placebo group, with >30 minutes of STD showing an RR of 4.33.

Conclusions:

• Transient ST depression on 24-hour monitoring significantly contributes to mortality in untreated early post-MI survivors.
• Propranolol's reduced effect suggests an anti-ischemic mechanism, potentially protecting against mortality.
• Further trials are warranted to explore if reducing STD improves survival outcomes.